(HealthDay News) — Here are the latest clinical trials, courtesy of CenterWatch:

Hereditary Angioedema

The companies purpose of this study is to determine the safety and effectiveness of an experimental drug when used to try to treat angioedema attacks. You may participate in this trial if you are 10 years old or older and have been diagnosed with hereditary angioedema. Research site located in Great Neck, NY.

More Information

Please see http://www.centerwatch.com/patient/studies/cat653.html.

—–

Epilepsy

Medtronic, Inc. is sponsoring an investigational study of the Intercept Epilepsy Control System, the company’s direct brain stimulation therapy for patients with refractory epilepsy. To qualify, you must have partial-onset seizures with or without secondary generalization, an average of six or more partial-onset seizures per month, and be between 18 and 65 years of age. Research sites located in New York and Indiana.

More Information

Please see http://www.centerwatch.com/patient/studies/cat62.html.

—–

Lung Cancer

This study will evaluate the effects of an investigational drug in addition to standard chemotherapy in patients with advanced non-small cell lung cancer that cannot be treated with surgery. Participants must be at least 18 years old, and women must not be pregnant or attempting to become pregnant. Research sites located throughout the United States.

More Information

Please see http://www.centerwatch.com/patient/studies/cat34.html.

—–

Copyright 2005 CenterWatch. All rights reserved.